249 related articles for article (PubMed ID: 38487354)
1. An overview of anti-Hepatitis B virus flavonoids and their mechanisms of action.
Naderi M; Salavatiha Z; Gogoi U; Mohebbi A
Front Cell Infect Microbiol; 2024; 14():1356003. PubMed ID: 38487354
[TBL] [Abstract][Full Text] [Related]
2. Latest developments in the treatment of hepatitis B.
Dandri M; Petersen J
Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
[TBL] [Abstract][Full Text] [Related]
3. Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs.
Huang H; Zhou W; Zhu H; Zhou P; Shi X
Toxicol Appl Pharmacol; 2017 May; 323():36-43. PubMed ID: 28322895
[TBL] [Abstract][Full Text] [Related]
4. (-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes.
Huang HC; Tao MH; Hung TM; Chen JC; Lin ZJ; Huang C
Antiviral Res; 2014 Nov; 111():100-11. PubMed ID: 25260897
[TBL] [Abstract][Full Text] [Related]
5. Management of viral hepatitis B.
Pramoolsinsup C
J Gastroenterol Hepatol; 2002 Feb; 17 Suppl():S125-45. PubMed ID: 12000599
[TBL] [Abstract][Full Text] [Related]
6. Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.
Ma Z; Zhang E; Yang D; Lu M
Cell Mol Immunol; 2015 May; 12(3):273-82. PubMed ID: 25418467
[TBL] [Abstract][Full Text] [Related]
7. New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus.
Durantel D; Zoulim F
J Hepatol; 2016 Apr; 64(1 Suppl):S117-S131. PubMed ID: 27084032
[TBL] [Abstract][Full Text] [Related]
8. Moving Fast Toward Hepatitis B Virus Elimination.
Bassit L; Ono SK; Schinazi RF
Adv Exp Med Biol; 2021; 1322():115-138. PubMed ID: 34258739
[TBL] [Abstract][Full Text] [Related]
9. New anti-hepatitis B virus drugs under development and evaluation.
Pan J; Tong S; Kang L; Tang J
Curr Opin Infect Dis; 2016 Dec; 29(6):632-638. PubMed ID: 27783030
[TBL] [Abstract][Full Text] [Related]
10. Past, Current, and Future Developments of Therapeutic Agents for Treatment of Chronic Hepatitis B Virus Infection.
Pei Y; Wang C; Yan SF; Liu G
J Med Chem; 2017 Aug; 60(15):6461-6479. PubMed ID: 28383274
[TBL] [Abstract][Full Text] [Related]
11. Anti-hepatitis B virus activity of food nutrients and potential mechanisms of action.
Jose-Abrego A; Rivera-Iñiguez I; Torres-Reyes LA; Roman S
Ann Hepatol; 2023; 28(4):100766. PubMed ID: 36179798
[TBL] [Abstract][Full Text] [Related]
12. Chinese herbal extract Su-duxing had potent inhibitory effects on both wild-type and entecavir-resistant hepatitis B virus (HBV) in vitro and effectively suppressed HBV replication in mouse model.
Liu Y; Yao W; Si L; Hou J; Wang J; Xu Z; Li W; Chen J; Li R; Li P; Bo L; Xiao X; Lan J; Xu D
Antiviral Res; 2018 Jul; 155():39-47. PubMed ID: 29702120
[TBL] [Abstract][Full Text] [Related]
13. Recent advance of the hepatitis B virus inhibitors: a medicinal chemistry overview.
Jia H; Rai D; Zhan P; Chen X; Jiang X; Liu X
Future Med Chem; 2015; 7(5):587-607. PubMed ID: 25921400
[TBL] [Abstract][Full Text] [Related]
14. Update on hepatitis B virus infection.
You CR; Lee SW; Jang JW; Yoon SK
World J Gastroenterol; 2014 Oct; 20(37):13293-305. PubMed ID: 25309066
[TBL] [Abstract][Full Text] [Related]
15. An Effective Antiviral Approach Targeting Hepatitis B Virus with NJK14047, a Novel and Selective Biphenyl Amide p38 Mitogen-Activated Protein Kinase Inhibitor.
Kim SY; Kim H; Kim SW; Lee NR; Yi CM; Heo J; Kim BJ; Kim NJ; Inn KS
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559272
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin gallate inhibits hepatitis B virus infection in human liver chimeric mice.
Lai YH; Sun CP; Huang HC; Chen JC; Liu HK; Huang C
BMC Complement Altern Med; 2018 Sep; 18(1):248. PubMed ID: 30189898
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Hepatitis B Virus Infection Induces Cytopathic Effects in Primary Human Hepatocytes, and Can Be Partially Reversed by Antiviral Therapy.
Zai W; Hu K; Ye J; Ding J; Huang C; Li Y; Fang Z; Wu M; Wang C; Chen J; Yuan Z
Microbiol Spectr; 2022 Feb; 10(1):e0132821. PubMed ID: 35171034
[TBL] [Abstract][Full Text] [Related]
18. [From the Establishment of Hepatitis B Virus Cell Culture Systems to Drug Discovery].
Fukano K; Watashi K
Yakugaku Zasshi; 2019; 139(1):81-87. PubMed ID: 30606935
[TBL] [Abstract][Full Text] [Related]
19. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
Delaney WE; Locarnini S; Shaw T
Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
[TBL] [Abstract][Full Text] [Related]
20. Naturally derived anti-hepatitis B virus agents and their mechanism of action.
Wu YH
World J Gastroenterol; 2016 Jan; 22(1):188-204. PubMed ID: 26755870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]